Neuroone Medical Technologies (NMTC) Cash from Investing Activities (2017 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Cash from Investing Activities came in at -$19659.0 in Q2 2026, up 54.86% on a YoY basis from -$12695.0 in Q2 2025, and up 48.96% quarter-over-quarter from -$38516.0 in Q1 2026.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported Cash from Investing Activities for 10 consecutive years, with -$19659.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities rose 54.86% year-over-year to -$19659.0; the trailing twelve-month figure through Jun 2026 stood at -$109536.0 (down 1.38% YoY), and the FY2025 full-year result was -$81742.0, up 31.99% from the prior year.
- Cash from Investing Activities climbed to -$19659.0 in Q2 2026 per NMTC's latest filing, from -$38516.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $1.8 million in Q1 2023 and bottomed at -$3.0 million in Q3 2022.
- Historically, Cash from Investing Activities has averaged -$46343.2 across 5 years, with a median of -$34132.5 in 2024.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities tumbled 8546.56% in 2022, then soared 2054.91% in 2023.
- Over 5 years, Cash from Investing Activities stood at $15069.0 in 2022, then slumped by 346.41% to -$37131.0 in 2023, then jumped by 34.24% to -$24416.0 in 2024, then sank by 66.92% to -$40754.0 in 2025, then soared by 51.76% to -$19659.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$19659.0, -$38516.0, and -$40754.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Neuroone Medical Technologies | 14.33 Mn | 12.29 Mn | 1.18 Mn | -19,659.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19,659.00 |
| Mar 31, 2026 | -38,516.00 |
| Dec 31, 2025 | -40,754.00 |
| Sep 30, 2025 | -10,607.00 |
| Jun 30, 2025 | -43,548.00 |
| Mar 31, 2025 | -3,171.00 |
| Dec 31, 2024 | -24,416.00 |
| Sep 30, 2024 | -36,905.00 |
| Jun 30, 2024 | -14,801.00 |
| Mar 31, 2024 | -31,360.00 |
| Dec 31, 2023 | -37,131.00 |
| Sep 30, 2023 | -50,120.00 |
| Jun 30, 2023 | 860,709.00 |
| Mar 31, 2023 | 1.82 Mn |
| Dec 31, 2022 | 15,069.00 |
| Sep 30, 2022 | -3.04 Mn |
| Jun 30, 2022 | -54,234.00 |
| Mar 31, 2022 | -93,319.00 |
| Dec 31, 2021 | -61,491.00 |
| Sep 30, 2021 | -35,109.00 |